You are here: Industry Insights > Breast Cancer

News List

A Review of the Great Journey of Capecitabine that Has Been Marketed in China for 20 Years PharmaSources/Wang Hong
November 10, 2020
Fluorouracil has been used in clinical treatment for more than half a century. Capecitabine, an oral prodrug of fluorouracil, is very convenient to use and is one of the classical chemotherapeutics widely used in clinical practice.
With personalized medicine, a shelved cancer drug could get another shot WorldPharmaNews
February 09, 2022
A study by Virginia Commonwealth University Massey Cancer Center researchers published in today's print edition of Molecular Cancer Therapeutics shows that triplatin is effective against triple negative breast cancer...
Immune-Based Therapy Shows Promise Against Advanced Breast Cancers drugs.com
February 09, 2022
An experimental therapy that harnesses the body's tumor-fighting immune cells...
Puma Biotechnology’s NERLYNX Included in Two Important NCCN Clinical Practice Guideline Updates for the Treatment of Breast Cancer FirstWordPharma
January 13, 2022
Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, announced that the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology (NCCN Guidelines) for the treatment...
Metabolic vulnerabilities could be new targets for metastatic breast cancer FirstWordPharma
January 13, 2022
Metabolic differences could explain why some metastatic breast cancer cells rapidly generate tumors after migrating from primary tumors to the brain, while others linger for months or years before forming these secondary tumors...
Overall Breast Cancer Incidence Decreased From 1999 to 2018 drugs.com
January 13, 2022
The incidence of breast cancer decreased overall from 1999 to 2018, but incidence increased among women aged 20 to 39 years and for non-Hispanic...
Tailored Strategies Can Up Depression Referrals in Breast Cancer drugs
January 04, 2022
For patients with newly diagnosed breast cancer, tailored strategies for implementation of routine depression screening result in a greater proportion of referrals to behavioral care, according to a study published in the Jan. 4 issue of the Journal of th
Breast Cancer Survival Up With Access to Integrative Therapies drugs
December 29, 2021
Institutional involvement in integrative oncology may increase survival for breast cancer patients, according to a study published online Dec. 18 in the Journal of Oncology.
Regor Therapeutics Announces U.S. FDA Authorization to Conduct Regor's First-in-Human Clinical Trial with the Next Generation Targeted Inhibitor RGT-419B for Oncology prnasia
December 28, 2021
On December 23, Regor Therapeutics, a clinical-stage biotech company, announced authorization from the US Food and Drug Administration (FDA) to proceed with Regor's Phase 1 clinical development plans for RGT-419B.
Everest Medicines Announces the Acceptance of a New Drug Application for Sacituzumab Govitecan in Second-Line Metastatic Triple-Negative Breast Cancer in South Korea prnasia
December 15, 2021
Everest Medicines Limited (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 26 27 Next page